Miloš Dičić
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Miloš Dičić has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Dušan Sokolović
Department of Biochemistry, Faculty of Medicine, University of Nis, 18000 Nis, Serbia
2 shared publications - Andrija Rančić
Clinic for Gastroenterohepatology, University Clinical Center of Niš, 18000 Niš, Serbia
1 shared publication - Bojan Vučković
Urology Department, General Hospital Prokuplje, 18400 Prokuplje, Serbia
1 shared publication - Elena Stanković
Clinic for Gastroenterology and Hepatology, University Clinical Center Niš, 18000 Niš, Serbia
1 shared publication - Ilija Ilic
Clinic for Gastroenterohepatology, University Clinical Center Nis, 18000 Nis, Serbia
1 shared publication - Ivan Ignjatović
Faculty of Medicine, University of Nis, 18000 Nis, Serbia
1 shared publication
Latest Publications
- Open Access
- 18 September 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (9) , 952
Tissue Biomarkers Outperform Plasma Signals in Pelvic Organ Prolapse: Evidence of a Dominant Extracellular Matrix Remodelling Phenotype
Pelvic floor disorders, particularly pelvic organ prolapse (POP) with or without stress urinary incontinence (SUI), are among the most prevalent benign conditions affecting women and are associated with substantial burdens. This study aimed to evaluate tissue extracellular matrix remodelling in women with POP with or without SUI by integrating clinical and phenotypic characteristics, and tissue and plasma specimens, and to determine whether the dominant biological signal is observed at the systemic or local tissue level in pelvic floor failure. Case–control analysis consisted of 121 women with POP with or without SUI and a control group (POP and SUI-free). Plasma and tissue concentrations of collagen type I, collagen type III, elastin, MMP-1, MMP-2, MMP-3, and MMP-9 were quantified (60 POP with or without SUI, 61 controls). Clinical and demographic characteristics were compared between groups, and secondary correlations between tissue biomarkers, pelvic floor symptom scores, and POP-Q parameters were evaluated within the POP group. The results of the present study reveal that the studied women were older, had higher BMI, parity, and vaginal delivery burden, and had markedly higher symptom scores. Plasma biomarkers showed limited differences between groups, whereas tissue biomarkers showed strong separation: COL1 and ELN were lower, while COL3, MMP1, MMP2, MMP3, and MMP9 were higher in POP. The strongest individual discriminatory markers were found to be MMP2 (AUC 0.958) and MMP9 (AUC 0.977). In adjusted models controlling age, BMI, and parity, parameters such as COL1, COL3, ELN, MMP2, MMP3, and MMP9 remained independently associated with POP. In this cohort, pelvic organ prolapse is associated with a robust extracellular matrix remodelling signature in vaginal-wall tissue, characterised by reduced structural components and increased MMP levels. Tissue biomarkers, particularly MMP-2 and MMP-9, may represent markers of the POP-associated tissue phenotype and warrant further validation in larger cohorts.
- 18 September 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (9) , 952
Open AccessTissue Biomarkers Outperform Plasma Signals in Pelvic Organ Prolapse: Evidence of a Dominant Extracellular Matrix Remodelling Phenotype
Pelvic floor disorders, particularly pelvic organ prolapse (POP) with or without stress urinary incontinence (SUI), are among the most prevalent benign conditions affecting women and are associated with substantial burdens. This study aimed to evaluate tissue extracellular matrix remodelling in women with POP with or without SUI by integrating clinical and phenotypic characteristics, and tissue and plasma specimens, and to determine whether the dominant biological signal is observed at the systemic or local tissue level in pelvic floor failure. Case–control analysis consisted of 121 women with POP with or without SUI and a control group (POP and SUI-free). Plasma and tissue concentrations of collagen type I, collagen type III, elastin, MMP-1, MMP-2, MMP-3, and MMP-9 were quantified (60 POP with or without SUI, 61 controls). Clinical and demographic characteristics were compared between groups, and secondary correlations between tissue biomarkers, pelvic floor symptom scores, and POP-Q parameters were evaluated within the POP group. The results of the present study reveal that the studied women were older, had higher BMI, parity, and vaginal delivery burden, and had markedly higher symptom scores. Plasma biomarkers showed limited differences between groups, whereas tissue biomarkers showed strong separation: COL1 and ELN were lower, while COL3, MMP1, MMP2, MMP3, and MMP9 were higher in POP. The strongest individual discriminatory markers were found to be MMP2 (AUC 0.958) and MMP9 (AUC 0.977). In adjusted models controlling age, BMI, and parity, parameters such as COL1, COL3, ELN, MMP2, MMP3, and MMP9 remained independently associated with POP. In this cohort, pelvic organ prolapse is associated with a robust extracellular matrix remodelling signature in vaginal-wall tissue, characterised by reduced structural components and increased MMP levels. Tissue biomarkers, particularly MMP-2 and MMP-9, may represent markers of the POP-associated tissue phenotype and warrant further validation in larger cohorts.
- Open Access
- 4 November 2025
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (11) , 914
Lycopene Mitigates Rat Liver Damage Induced by Lipopolysaccharide via Mechanisms Involving Oxidative Stress, Inflammation, and Apoptosis
Background: Sepsis is a leading cause of mortality in intensive care units, with liver dysfunction representing a critical determinant of poor outcome, mainly associated with excessive inflammation and oxidative stress. Lycopene, a carotenoid with potent antioxidant and anti-inflammatory properties, has been proposed as a potential therapeutic agent. This study investigated whether lycopene supplementation mitigates lipopolysaccharide-induced oxidative and inflammatory liver injury in rats. Methods: Male Wistar rats, divided into four groups, were exposed to either lipopolysaccharide or a combination of lipopolysaccharide (10 mg/kg) and lycopene (6 mg/kg). In order to assess liver damage induced by lipopolysaccharide, hepatocellular injury markers, oxidative stress indices, nitric oxide metabolism, glutathione redox status, apoptotic enzyme activity, and inflammatory mediators were assessed in serum and liver tissue. Results: Lipopolysaccharide induced marked hepatocellular damage, characterized by elevated serum liver-cell damage parameters, and liver tissue xanthine oxidase, myeloperoxidase, thiobrabituric reactive substances, protein carbonyl content, deoxyribonuclease I/II activity, nuclear factor kappa B, tumor necrosis factor-α, and interleukin-6, alongside depletion of reduced glutathione and reduced glutathione reductase and glutathione peroxidase activities. Lyc pretreatment significantly attenuated liver enzyme leakage, oxidative damage, and cytokine release while restoring reduced glutathione and glutathione reductase activity. In contrast, lycopene had limited effects on glutathione peroxidase activity, nitric oxide/inducible nitric oxide synthase signaling, and nuclear factor erythroid 2-related factor 2 expression. Conclusions: These findings demonstrate that lycopene confers partial hepatoprotection in endotoxemic rats, primarily through suppression of oxidative damage and nuclear factor kappa B-mediated inflammation. Further studies are needed to clarify tissue-specific mechanisms and optimize dosing strategies in order to increase the efficacy of this carotenoid.
- 4 November 2025
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (11) , 914
Open AccessLycopene Mitigates Rat Liver Damage Induced by Lipopolysaccharide via Mechanisms Involving Oxidative Stress, Inflammation, and Apoptosis
Background: Sepsis is a leading cause of mortality in intensive care units, with liver dysfunction representing a critical determinant of poor outcome, mainly associated with excessive inflammation and oxidative stress. Lycopene, a carotenoid with potent antioxidant and anti-inflammatory properties, has been proposed as a potential therapeutic agent. This study investigated whether lycopene supplementation mitigates lipopolysaccharide-induced oxidative and inflammatory liver injury in rats. Methods: Male Wistar rats, divided into four groups, were exposed to either lipopolysaccharide or a combination of lipopolysaccharide (10 mg/kg) and lycopene (6 mg/kg). In order to assess liver damage induced by lipopolysaccharide, hepatocellular injury markers, oxidative stress indices, nitric oxide metabolism, glutathione redox status, apoptotic enzyme activity, and inflammatory mediators were assessed in serum and liver tissue. Results: Lipopolysaccharide induced marked hepatocellular damage, characterized by elevated serum liver-cell damage parameters, and liver tissue xanthine oxidase, myeloperoxidase, thiobrabituric reactive substances, protein carbonyl content, deoxyribonuclease I/II activity, nuclear factor kappa B, tumor necrosis factor-α, and interleukin-6, alongside depletion of reduced glutathione and reduced glutathione reductase and glutathione peroxidase activities. Lyc pretreatment significantly attenuated liver enzyme leakage, oxidative damage, and cytokine release while restoring reduced glutathione and glutathione reductase activity. In contrast, lycopene had limited effects on glutathione peroxidase activity, nitric oxide/inducible nitric oxide synthase signaling, and nuclear factor erythroid 2-related factor 2 expression. Conclusions: These findings demonstrate that lycopene confers partial hepatoprotection in endotoxemic rats, primarily through suppression of oxidative damage and nuclear factor kappa B-mediated inflammation. Further studies are needed to clarify tissue-specific mechanisms and optimize dosing strategies in order to increase the efficacy of this carotenoid.